文献速递临床试验与 GCP

改善乳腺癌随访的乳腺癌后护理(BETTER-CARE)项目:整群随机复杂干预试验的设计与可行性研究结果

The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial.
PubMed 文献 · Trials · 2024-11-14

BETTER-CARE是一项在德国15个干预中心和15个对照中心开展的平行组整群随机对照试验,计划招募1140例患者,旨在评估基于需求和风险适应的个体化乳腺癌随访护理。2个月试点阶段纳入1个干预中心与1个对照中心共16例患者,结果显示该干预和研究方案可行。

要点

  • BETTER-CARE是一项在德国开展的平行组整群随机对照试验,设15个干预中心和15个对照中心,计划招募1140例患者。
  • 干预为基于现有开发框架的需求与风险适应复杂干预,包括多学科网络和数字平台用于症状与需求记录及即时自适应干预。
  • 2个月试点阶段纳入1个干预中心和1个对照中心共16例患者,显示BETTER-CARE方案可行。

核心结论

  • BETTER-CARE是一项可行的干预和研究方案,在德国研究个体化的需求与风险适应乳腺癌随访护理。
  • 若研究成功,该方法或可在德国常规护理中实施。

研究设计与样本

  • BETTER-CARE为平行组整群随机对照试验,在15个干预中心和15个对照中心开展,计划招募1140例患者。
  • 对照组接受根据临床指南的常规护理。
  • 主要结局为健康相关生活质量(EORTC QLQ-C30整体健康),次要结局包括治疗依从性。
  • 试验注册于德国临床试验注册中心DRKS00028840,注册时间为2022年4月。

主要发现

  • 2个月试点阶段纳入1个干预中心和1个对照中心共16例患者,显示BETTER-CARE方法的可行性。

关键数值与推荐

  • 干预为基于现有开发框架的需求与风险适应复杂干预,包括多学科网络和数字平台用于症状与需求记录及即时自适应干预。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The risk of breast cancer patients for long-term side effects of therapy such as neurotoxicity and cardiotoxicity as well as late effects regarding comorbidities varies from individual to individual. Personalised follow-up care concepts that are tailored to individual needs and the risk of recurrences, side effects and late effects are lacking in routine care in Germany. METHODS: We describe the methodology of BETTER-CARE, a parallel-arm cluster-randomised controlled trial conducted at 15 intervention and 15 control centres, aiming to recruit 1140 patients, and the results of the pilot phase. The needs- and risk-adapted complex intervention, based on existing development frameworks, includes a multidisciplinary network and digital platforms for symptom and need documentation and just-in-time adaptive interventions. The control group comprises usual care according to clinical guidelines. The primary outcome is health-related quality of life (EORTC QLQ-C30 global health), and secondary outcomes include treatment adherence. RESULTS: The 2-month pilot phase comprising 16 patients in one intervention and one control pilot centre demonstrated the feasibility of the BETTER-CARE approach. DISCUSSION: BETTER-CARE is a feasible intervention and study concept, investigating individualised needs- and risk-adapted breast cancer follow-up care in Germany. If successful, the approach could be implemented in German routine care. TRIAL REGISTRATION: German Clinical Trial Register DRKS00028840. Registered on April 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Schäfer A, Wendel J, Franke I, et al. The BrEasT cancer afTER-CARE (BETTER-CARE) programme to improve breast cancer follow-up: design and feasibility study results of a cluster-randomised complex intervention trial. Trials. 2024. PMID: 39543763. doi:10.1186/s13063-024-08614-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。